Ambimed Group

VACCINE AGAINST MENINGOCOCCAL DISEASE (GROUPS A, C, W, Y)

* The price shown does not include the administrative expenses of the medical facility

Cos'è il papilloma-virus

What is
meningitis?

Learn more

Come si trasmette l'infezione

Why prevention
is important

Learn more

A chi è consigliato il vaccino

When to
vaccinate

Learn more

Quando è preferibile vaccinarsi

Vaccine
composition

Learn more

MENJUGATE;

MENCEVAX;

MENVEO;

NIMENRIX (meningococcal group A, C, W, Y)

It is administered intramuscularly.

The monovalent vaccine includes 2 doses at least 2 months apart for children aged between 2 months and 1 year. The tetravalent vaccine includes a booster between the ages of 12 and 18 years for individuals who were vaccinated in childhood.

The most frequently reported adverse reactions are pain, redness and induration at the injection site, malaise, fever, headache, irritability and gastrointestinal symptoms.

Vaccine administration must be postponed in individuals with acute febrile infections. Contraindications to the meningococcal vaccine are hypersensitivity to any of the active ingredients or any of the excipients.

A careful risk-benefit assessment by a medical specialist is necessary when considering the vaccination of pregnant or breastfeeding women.

Your safety and health are the heart of our commitment.
You can always count on the experience and expertise of the Ambimed team.
Do you need more information or assistance with your booking?
Call your dedicated assistant

02 87399117

The information presented is general in nature, is published for informational purposes for a general public and does not replace the relationship between patient and doctor.
Do you find this article interesting? Share it on social networks
Design and development by TECNASOFT